PLAAT3 and familial pancreatic carcinoma: These cumulative findings corroborate the consistently heightened expression of PLA2G16 in individuals diagnosed with pancreatic cancer, underscoring the potential significant role of PLA2G16 in the pathogenesis of pancreatic cancer.